difficile bacteria. Acetate is a short-chain fatty acid produced by the digestion of soluble fibers, a process carried out by the bacteria that live in the intestine. In the study, mice fed a low ...

About LMN-201 and Lumen Bio LMN-201 is orally delivered (capsules; no enema or "bowel cleanse" required) and highly scalable, allowing for much broader potential use in routine CDI management.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Recurrent CDI is an excellent example of alteration of the microbiome, which leads to disease. The use of probiotics has had limited success in treatment of this illness. By contrast, FMT has been ...

13 Highlights From ACG 2022 Dr David Johnson shares the latest data from this year's meeting, which range from novel treatments for C difficile to the use of virtual reality in treating dyspepsia.

Eleven children with RCDI underwent FMT from Shanghai Children’s Hospital, China, between September 2014 and December 2017, were enrolled to the study cohort. This study was approved by the Regional ...